The recent advancements achieved in the development of a fluid-to-fluid similarity theory for heat transfer with fluids at supercritical pressures are summarised. The prime mover for the development of the theory was the interest in the development of Supercritical Water nuclear Reactors (SCWRs) in the frame of research being developed worldwide; however, the theory is general and can be applied to any system involving fluids at a supercritical pressure. The steps involved in the development of the rationale at the basis of the theory are discussed and presented in a synthetic form, highlighting the relevance of the results achieved so far and separately published elsewhere, with the aim to provide a complete overview of the potential involved in the application of the theory. The adopted rationale, completely different from the ones in the previous literature on the subject, was based on a specific definition of similarity, aiming to achieve, as much as possible, similar distributions of enthalpies and fluid densities in a duct containing fluids at a supercritical pressure. This provides sufficient assurance that the complex phenomena governing heat transfer in the addressed conditions, which heavily depend on the changes in fluid density and in other thermophysical properties along and across the flow duct, are represented in sufficient similarity. The developed rationale can be used for planning possible counterpart experiments, with the aid of supporting computational fluid-dynamic (CFD) calculations, and it also clarifies the role of relevant dimensionless numbers in setting up semi-empirical correlations for heat transfer in these difficult conditions, experiencing normal, enhanced and deteriorated regimes. This paper is intended as a contribution to a common reflection on the results achieved so far in view of the assessment of a sufficient body of knowledge and understanding to base successful predictive capabilities for heat transfer with fluids at supercritical pressures.
Autism spectrum disorder (ASD) is a neurodevelopmental disorder. Autism Spectrum Disorder is diagnosed early on in a child's life, anywhere from eighteen to twenty-four months. The disorder is characterized by variable degrees, by difficulties in nonverbal communication, verbal communication, social interaction, repetitive behaviors, and movement. The occurrence of ASD has been increasing globally, with the most recent prevalence studies indicating that they are present in six per one thousand children and one in every sixty-eight people of all ages, with a higher incidence among males, with a ratio of four to one. There is no specific target demographic for Autism Spectrum Disorder, nor is there a cure. Over the last few decades, there have been advancements in treating the symptoms associated with Autism Spectrum Disorder. Among the many different fields of research associated with Autism Spectrum Disorder, Bumetanide has shown to be a promising drug therapy for children suffering from Autism, treating specifically the behavioral symptoms associated with ASD. Bumetanide is forty times more potent than furosemide and is a loop diuretic mainly acting in the ascending limb of the loop of Henle. A clinical trial conducted found a decrease in the Childhood Autism Rating Scale (CARS) score, showing improvement in Autism Spectrum Disorder symptoms, such as repetitive behavior and initiating or participating in the social interaction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.